V021-5332 Screening compound: N-[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-(2-methoxyethyl)formamido]acetamide

V021-5332 Screening compound: N-[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-(2-methoxyethyl)formamido]acetamide
V021-5332 Screening compound: N-[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-(2-methoxyethyl)formamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V021-5332
N-[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-(2-methoxyethyl)formamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V021-5332

Molecular Formula

C29H29FN4O5 (C29 H29 FN4 O5)

Compound Name

N-[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-(2-methoxyethyl)formamido]acetamide

IUPAC name

N-[14-bis(4-methoxyphenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-(2-methoxyethyl)formamido]acetamide

SMILES

COCCN(CC(Nc1nc(-c(cc2)ccc2OC)cn1-c(cc1)ccc1OC)=O)C(c(cc1)ccc1F)=O

InChI

InChI=1S/C29H29FN4O5/c1-37-17-16-33(28(36)21-4-8-22(30)9-5-21)19-27(35)32-29-31-26(20-6-12-24(38-2)13-7-20)18-34(29)23-10-14-25(39-3)15-11-23/h4-15,18H,16-17,19H2,1-3H3,(H,31,32,35)

InChI Key

NMLPPUPRGBYAIP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19826479

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

532.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.465

Distribution Coefficient, logD

4.465

Water Solubility, LogSw

-4.11

Polar Surface Area

76.073

Acid Dissociation Constant (pKa)

13.10

Base Dissociation Constant (pKb)

2.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.70

V021-5332 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V021-5332 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V021-5332?
Check Price and Availability of V021-5332, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V021-5332 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V021-5332
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V021-5332
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V021-5332 available by request